BioStacks

Supplement

Phosphatidylinositol

Evidence

Limited
Evidence: 2 of 5 (Limited)

What the evidence says

A minor membrane phospholipid, usually supplied as a fraction of lecithin/phospholipid complexes. Unlike phosphatidylserine, phosphatidylinositol has essentially no standalone clinical evidence for cognition or any endpoint.

Minor phospholipid; no standalone clinical evidence.

Top Phosphatidylinositol supplements

About Phosphatidylinositol

A minor membrane phospholipid, usually supplied as a fraction of lecithin/phospholipid complexes. Unlike phosphatidylserine, phosphatidylinositol has essentially no standalone clinical evidence for cognition or any endpoint. Distinct from free inositol (myo-inositol). Grade low; it is a structural phospholipid, not a studied active.

What Phosphatidylinositol supports

  • Structural membrane phospholipid from lecithin

How much Phosphatidylinositol to take

The RDA prevents deficiency. The effective range is what clinical trials used to actually move the outcome.

Effective

1001000

mg

No established therapeutic dose; nominal range for a phospholipid blend component (typically from lecithin).

Clinical evidence

Limited clinical evidence. Minor phospholipid; no standalone clinical evidence.

Examine.com